Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Japanese researchers develop antimalarial agents

Nov. 17, 2016

FDA issues complete response letter for Heplisav-B BLA

Nov. 15, 2016

Katholieke Universiteit Leuven discloses PMDT nucleoside phosphonates

Nov. 15, 2016

Texas A&M University patents antimycobacterial agents

Nov. 15, 2016

EMA gives positive opinion on Gilead's MAA for Vemlidy

Nov. 14, 2016

Assembly Biosciences starts phase Ia/Ib trial of ABI-H0731

Nov. 11, 2016

FDA approves Vemlidy to treat chronic HBV infection

Nov. 11, 2016

FDA places clinical hold on Heparc-2004 study of ARC-520

Nov. 9, 2016

Positive interim data from an ongoing early clinical trial of CC-31244

Nov. 9, 2016

FDA grants several orphan drug designations to APX-001

Nov. 8, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...